A recent population-based cohort study offers more insight into the link between glycemic status and the risk for PD.
Read More »Managing Editor, Diabetes in Control
Semglee: Insulin Glargine “Biosimilar” Approved for Diabetes in the US
A milestone in the push for improved access and affordability of life-saving medications.
Read More »Insulin and Glucagon Co-administration – Optimizing Glycemic Control without Risks of Hypoglycemia
Opposing actions of insulin and glucagon may be the key to glucose control.
Read More »Leading Causes of Mortality in People with Diabetes
How is mortality related to ethnicity, age, sex, and other factors?
Read More »Examining the Risks of Antihyperglycemic Dual and Triple Therapies for T2D
A closer look at the risk of major adverse events, severe hypoglycemia, and all-cause mortality for commonly used therapies in treating type 2 diabetes.
Read More »Adapting to Pandemic Times: How to Manage Patients with Diabetes in the ICU
New diabetes mitigation plan in the intensive care unit during the COVID-19 pandemic.
Read More »Reducing Cardiovascular Events and Mortality with Monthly Lifestyle Modification Counseling
Lifestyle modifications can impact cardiovascular outcomes including myocardial infarction, strokes, and death.
Read More »Racial Disparities vs. Glycemic Control
Rushed communication between provider and patient is associated with reduced glycemic control in black patients.
Read More »Vitamin D Supplementation Reduces the Risk of T2DM
Large study finds both vitamin D dosage and patient BMI play a role in the effectiveness of supplementation in preventing T2DM.
Read More »Risks Associated with Age of Diabetes Onset
Compelling evidence suggests that the age of diabetes diagnosis may be linked to the risk of end-stage kidney disease.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.